JG
IRWD icon

Jefferies Group’s Ironwood Pharmaceuticals IRWD Stock Holding History

Jefferies Group’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-17,552
Closed -$152K – 2477
2018
Q4 		$152K Sell
17,552
-67,341
-79% -$773K ﹤0.01% 1901
2018
Q3 		$1.31M Sell
84,893
-4,657
-5% -$73.6K 0.01% 1188
2018
Q2 		$1.43M Buy
+89,550
New +$1.33M 0.01% 1064

Other funds holding IRWD

SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Jefferies Group's IRWD Position: Q2 2021 in Review

Jefferies Group sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2021, closing a stake of 394,640 shares — an estimated $4.52M sold.

Jefferies Group first reported a position in IRWD in Q4 2013 and held it in 16 quarters. The position peaked at $4.41M in Q1 2021. 208 funds tracked by Wall St. Rank hold IRWD as of Q2 2021.

  • Jefferies Group reported no remaining Ironwood Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Jefferies Group sold 394,640 Ironwood Pharmaceuticals shares in Q2 2021, an estimated $4.52M.
  • Jefferies Group first reported a position in Ironwood Pharmaceuticals in Q4 2013 and held it in 16 quarters.
  • Jefferies Group's Ironwood Pharmaceuticals position peaked at $4.41M in Q1 2021.
  • 208 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2021.

Based on Jefferies Group's 13F filing for Q2 2021, filed 16 Aug 2021.